You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. KODIAK SCIENCES INC

Kodiak Sciences Inc XNAS: KOD

Kodiak Sciences Inc Live Share Price Today, Share Analysis and Chart

Download real time

3.20 0.36 (12.68%)

72.41% Fall from 52W High

947.4K XNAS Volume

High volume+gain today

XNAS 21 Apr, 2025 3:57 PM (EDT)

Watchlist

Portfolio

Share

Kodiak Sciences Inc Key Metrics

Select

Market Capitalization

Below industry Median
168.8

PE TTM

Negative PE TTM
-1

Price to Book

Below industry Median
1.1

Institutional holding current Qtr %

Below industry Median
76.9

Net Profit Qtr Growth YoY %

Below industry Median
25.9

Net Profit TTM Growth %

Below industry Median
32.4

Piotroski Score

Below industry Median
1

Rel Perf vs Sector quarter%

-54.6

ROE Annual %

Negative ROE Annual %
-84.7

RoA Annual %

Negative RoA Annual %
-43.2
All financials are in USD Million and price data in USD
VIEW MORE
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
10.5 / 100
Momentum Score
Technically Neutral
36.1 / 100
Analyst Price Target
No estimates available

19

S

9

W

2

O

2

T

SWOT Analysis

Check P/E Buy Sell Zone

This stock has negative PE


Kodiak Sciences Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Kodiak Sciences Inc Stock Analysis

Kodiak Sciences Inc stock analysis with key metrics, changes, and trends.

Kodiak Sciences Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Net Profit$176.21 M32.36%positive

Annual Net Profit rose 32.36% in the last year to $176.21 M. Its sector's average net profit growth for the last fiscal year was -30.36%.

Price to Earning Ratio-0.96-negative

Price to Earning Ratio is -0.96, which is negative.

Stock Price$3.20-4.76%negative

Stock Price fell 4.76% and underperformed its sector by 11.42% in the past year.

Quarterly Net profit$44.1 M25.89%positive

Quarterly Net profit rose 25.89% YoY to $44.1 M. Its sector's average net profit growth YoY for the quarter was -48.37%.

Debt to Equity Ratio0.47-positive

Debt to Equity Ratio of 0.47 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)-84.70 %-84.7%negative

Return on Equity(ROE) for the last financial year was -84.7%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding21.09 %0.88%positive

Mutual Fund Holding increased by 0.88% in the last quarter to 21.09.

Promoter Share Holding8.34 %0%neutral

Promoter Share Holding stayed the same in the most recent quarter at 8.34%.

Institutional Holding76.87 %-0.04%negative

Institutional Holding decreased by 0.04% in the last quarter to 76.87.

VIEW LESS


Loading data..

Kodiak Sciences Inc - Company Profile

What does Kodiak Sciences Inc do?

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

Kodiak Sciences Inc Management structure

All Gross Remunerations are in USD
Dr. Victor Perlroth, M.D.
Chief Executive Officer, President and Chairman of the Board
-
2024
Gross Remuneration
Year
Mr. John A. Borgeson
Executive Vice President, Chief Financial Officer, Secretary and Principal Accounting Officer
-
2024
Gross Remuneration
Year

Kodiak Sciences Inc Board of directors

All Gross Remunerations are in USD
Mr. Robert A. Profusek
Lead Independent Director
-
2024
Gross Remuneration
Year
Dr. Taiyin Yang, PhD
Independent Director
-
2024
Gross Remuneration
Year
Dr. Felix J. Baker,PhD
Independent Director
-
2024
Gross Remuneration
Year
Dr. Richard S. Levy,M.D.
Independent Director
-
2024
Gross Remuneration
Year
Mr. Charles A. Bancroft
Independent Director
-
2024
Gross Remuneration
Year
Dr. Bassil I. Dahiyat, PhD.
Independent Director
-
2024
Gross Remuneration
Year

Kodiak Sciences Inc FAQ

How is Kodiak Sciences Inc today?
Kodiak Sciences Inc today is trading in the green, and is up by 12.68% at 3.20.
Kodiak Sciences Inc is currently trading up 12.68% on an intraday basis. In the past week the stock rose 46.79%. stock has been down -55.37% in the past quarter and fell -4.76% in the past year. You can view this in the overview section.